Ignacio Aldana Selected Research

Ignacio Aldana Research Topics

8	Obesity 06/2012 - 01/2004
6	Malaria 10/2020 - 10/2009
5	Tuberculosis (Tuberculoses) 06/2011 - 09/2008
2	Infections 10/2018 - 04/2011
2	Neglected Diseases 08/2013 - 06/2009
2	Leishmaniasis 04/2013 - 08/2011
2	Edema (Dropsy) 04/2011 - 12/2007
1	Chagas Disease (American Trypanosomiasis) 08/2013
1	Type 2 Diabetes Mellitus (MODY) 06/2012

4	quindoxinIBA 10/2018 - 04/2011
3	QuinoxalinesIBA 04/2013 - 09/2008
3	Antitubercular AgentsIBA 06/2011 - 09/2008
3	Neuropeptide YIBA 01/2005 - 01/2004
2	Chloroquine (Aralen)FDA LinkGeneric 10/2020 - 09/2012
2	Antimalarials (Antimalarial Agents)IBA 04/2013 - 08/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 06/2011 - 09/2008
2	AerosolsIBA 04/2011 - 09/2008
2	CarrageenanIBA 04/2011 - 12/2007
2	melanin-concentrating hormone (melanin concentrating hormone)IBA 11/2010 - 01/2008
2	melanin-concentrating hormone receptorIBA 01/2008 - 01/2008
1	Primaquine FDA Link 10/2018
1	Pyrimethamine (Daraprim)FDA Link 09/2012
1	Methylene Blue (Methylthioninium Chloride)FDA Link 09/2012
1	Quinine (Quinson)FDA Link 09/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2012
1	BR 76 (BR 1376)IBA 08/2011
1	quinoxaline-2-carbonitrileIBA 08/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2011
1	Melanins (Melanin)IBA 11/2010
1	quinoxaline-2-carboxamideIBA 10/2010
1	1-Propanol (Propanol)IBA 10/2009
1	AcidsIBA 06/2009
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2008
1	pretomanidIBA 09/2008
1	AmidesIBA 01/2008
1	Urea (Carbamide)FDA LinkGeneric 06/2007
1	HydrazinesIBA 09/2004

1	Therapeutics 11/2017